Tech Company Financing Transactions
Ensemble Discovery Funding Round
Ensemble Discovery secured a $5 million venture capital round on 6/30/2007. Investors included Flagship Pioneering and Oxford Bioscience Partners.
Transaction Overview
Company Name
Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Flagship Pioneering (Noubar Afeyan)
Oxford Bioscience Partners (Mark Carthy)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
35 Norman St.
Salem, MA 01970
USA
Salem, MA 01970
USA
Phone
Website
Email Address
Overview
Ensemble is focused on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. We are aggressively applying our proprietary drug discovery platform to go beyond the boundaries of traditional therapeutics by developing novel small molecules against challenging disease targets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Taylor
Chief Scientific Officer
Nick Terrett
Vice President
Stephen Hale
Vice President
David Livingston
VP - Bus. Development
Ted Hibben
VP - Finance
Andrea Szekely-Hill
Browse more venture capital transactions:
Prev: 6/30/2007: NovoStent venture capital transaction
Next: 6/30/2007: Juniper Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs